Your immune system got all the training it needed from the 1st jab.
This is, of course, not true. The Spike is only one protein.
And the Spike made from mRNA jabs is not identical to any naturally found Spike protein due to the pseudo-Uridine it contains, making it longer lasting and immune system disrupting:
https://yournews.com...ng-clots-heart/
"Cole said mRNA is a message that tells your cell to make a certain protein for different body reactions.
“But when you put this synthetic pseudouridine [in your body],” said Cole. “The body doesn’t know what to do with it, and it looks at it and says, ‘Hmm, I don’t know what to do. So I’m not going to break it down.’ And so it evades that breakdown process, and it also evades an immune response. But it also turns down our immune system, which is not a good thing because other things—cancers, viruses—get to wake up.”
In a February interview with The Epoch Times, Cole said that he had seen an uptick in cancers that he shouldn’t be seeing. In addition, he has seen elevations and clotting factors persisting for a long time post-vaccination. However, when he voiced his concerns, no government agencies were willing to look into this finding."
Natural immunity arrises from exposure to all the proteins of the Virus and will always be superior:
https://www.swfinsti...o-covid-vaccine
"There was also a July 2021 study called “Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells”
The study essentially highlights that most recovered COVID-19 patients mount broad, durable immunity after infection.
LINK:
https://www.cell.com...t/S2666-3791(21)00203-2
The abstract reads, “Ending the COVID-19 pandemic will require long-lived immunity to SARS-CoV-2. Here, we evaluate 254 COVID-19 patients longitudinally up to 8 months and find durable broad-based immune responses. SARS-CoV-2 spike binding and neutralizing antibodies exhibit a bi-phasic decay with an extended half-life of >200 days suggesting the generation of longer-lived plasma cells. SARS-CoV-2 infection also boosts antibody titers to SARS-CoV-1 and common betacoronaviruses. In addition, spike-specific IgG+ memory B cells persist, which bodes well for a rapid antibody response upon virus re-exposure or vaccination. Virus-specific CD4+ and CD8+ T cells are polyfunctional and maintained with an estimated half-life of 200 days. Interestingly, CD4+ T cell responses equally target several SARS-CoV-2 proteins, whereas the CD8+ T cell responses preferentially target the nucleoprotein, highlighting the potential importance of including the nucleoprotein in future vaccines. Taken together, these results suggest that broad and effective immunity may persist long-term in recovered COVID-19 patients.”
"
"